Supplementary Figure 2 from Low-Dose Metronomic Oral Dosing of a Prodrug of Gemcitabine (LY2334737) Causes Antitumor Effects in the Absence of Inhibition of Systemic Vasculogenesis

Autor:	Robert S. Kerbel, F. Stuart Foster, Anne H. Dantzig, Mark Uhlik, Julie Stewart, Christina Hackl, Shan Man, Ping Xu, Carolyn Cesta, Melissa Yin, John Sun, Kae Hashimoto, Yuval Shaked, Giulio Francia
Rok vydání:	2023
DOI:	10.1158/1535-7163.22497943
Popis:	PDF file - 6.5MB
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1095e22a6c3908d93022cb07fe566f2a https://doi.org/10.1158/1535-7163.22497943 Zobrazit plný text záznamu